How to perform a cardio-thoracic magnetic resonance imaging in COVID-19: comprehensive assessment of heart, pulmonary arteries, and lung parenchyma.
Nicola GaleaFederica CatapanoLivia MarchitelliGiulia CundariViviana MaestriniValeria PanebiancoMassimo ManconeFrancesco FedeleCarlo CatalanoMarco FranconePublished in: European heart journal. Cardiovascular Imaging (2021)
We proposed a combined cardiothoracic-MRI (CaTh-MRI) protocol for the comprehensive assessment of cardiovascular structures, lung parenchyma, and pulmonary arterial tree, in COVID-19 patients with progressive worsening of clinical conditions and/or suspicion of acute-onset myocardial inflammation. A 25-minutes fast protocol was also conceived for unstable or uncooperative patients by restricting the number of sequences to those necessary to rule out myocardial and to assess pulmonary involvement. In patients requiring CMR characterization of myocardial damage, the addition of lung and thoracic vessel evaluation is of clinical benefit at a minimal time expense.
Keyphrases
- end stage renal disease
- coronavirus disease
- pulmonary hypertension
- ejection fraction
- sars cov
- newly diagnosed
- randomized controlled trial
- left ventricular
- magnetic resonance imaging
- oxidative stress
- peritoneal dialysis
- prognostic factors
- spinal cord
- magnetic resonance
- high resolution
- intensive care unit
- liver failure
- computed tomography
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation